ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633781 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633781; 2) Community: the network communities that were significantly associated with the response to NSC 633781; 3) Molecule: the relationships between components within communities and NSC 633781; 4) MDR: the compounds that were significantly associated with the NSC 633781.

NSC Compound Enrichment Correlation
NSC 671392 Null 0.0284045326811618 0.10752602
NSC 672453 Null 0.0284045326811618 0.11480538
NSC 677275 Null 0.0284045326811618 0.050174303
NSC 677776 Null 0.0284045326811618 0.27488135
NSC 681636 Camptothecin Derivative 0.0284045326811618 0.39161417
NSC 682763 Null 0.0284045326811618 0.19210226
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0284045326811618 0.46924297
NSC 685862 Null 0.0284045326811618 0.12592085
NSC 690270 ANTINEOPLASTIC-690270 0.0284045326811618 0.018446131
NSC 693986 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, 0.0284045326811618 0.0033096476
Total:78  Current:45    [First] [Prev] [Next] [Last]